天然产物研究与开发 ›› 2026, Vol. 38 ›› Issue (9): 2021-2033.doi: 10.16333/j.1001-6880.2026.9.016 cstr: 32307.14.1001-6880.2026.9.016

• 数据研究 • 上一篇    下一篇

基于网络药理学及实验验证探究化橘红治疗高脂血症的作用机制

郭钧榕,邝思颖,张卓雅,黄祖润,熊  平 ∗   

  1. 华南农业大学材料与化工学院,广州510642

  • 出版日期:2026-09-24 发布日期:2026-09-22
  • 基金资助:

    国家科技部重点研发专项(2018YFC1706702)

Mechanism of Citri Grandis Exocarpium in the treatment of hyperlipidemia based on network pharmacology and experimental validation

GUO Jun-rong,KUANG Si-ying,ZHANG Zhuo-ya,HUANG Zu-run,XIONG Ping∗   

  1. College of Materials and Chemical Engineering,South China Agricultural University,Guangzhou 510642,China

  • Online:2026-09-24 Published:2026-09-22

摘要:

基于网络药理学及实验验证深入探究化橘红(Citri Grandis Exocarpium,CGE)治疗高脂血症的潜在作用机制。通过TCMSP、STRING 等数据库筛选CGE 活性成分及作用靶点与高脂血症靶点,并与高脂血症相关靶点取交集构建蛋白互作网络,对核心靶点进行GO 功能注释和KEGG 通路富集;利用分子对接模拟活性成分与关键靶点的结合能力。进一步采用油酸诱导建立HepG2 细胞脂质沉积模型,给予不同浓度CGE 处理,通过油红O 染色、甘油三酯 (triglyceride,TG)和总胆固醇(total cholesterol,TC)含量检测以及Western blot 分析对其作用进行验证。经筛选分析获得20 个CGE 潜在作用靶点,核心活性成分包括柚皮素、异橙黄酮和芹菜素等,关键靶点主要涉及半胱天冬酶3 (cysteine-aspartic acid protease 3,CASP3)、丝氨酸/ 苏氨酸蛋白激酶1(serine/ threonine kinase 1,AKT1)和前列腺素内过氧化物合酶2(prostaglandin-endoperoxide synthase 2,PTGS2)等。GO 富集提示CGE 可能通过调控凋亡过程、脂多糖应答及蛋白质磷酸化等生物过程发挥作用;KEGG 富集结果显示其主要涉及代谢通路及磷脂酰肌醇3-激酶/ 蛋白激酶B(phosphoinositide 3-kinase/ protein kinase B,PI3K/ AKT)信号通路。分子对接结果表明核心成分与关键靶点具有良好的结合活性,其中柚皮素与CASP3(-6. 5 kcal/ mol)和芹菜素与AKT1(-6. 15 kcal/ mol)表现出最佳结合能。体外实验结果显示,0. 2 mmol/ L 油酸可成功诱导HepG2 细胞脂质沉积模型,CGE 处理能剂量依赖性减少脂滴积聚,油红 O 阳性面积由39. 89% 显著降低至19. 4% ~ 23. 92% ,并显著降低TG 和TC 含量,其中2 mg/ mL 组作用最为显著。 同时,CGE 通过抑制PI3K/ AKT 信号通路,进而阻断脂质合成。综上,CGE 可通过调节肝细胞脂质代谢相关信号通路,减少脂质沉积并降低细胞内TG 和TC 水平,发挥潜在的降脂作用。

关键词:

"> 化橘红, 高脂血症, 网络药理学, 分子对接, HepG2 细胞

Abstract:

This study aims to explore the mechanism of Citri Grandis Exocarpium (CGE) in the treatment of hyperlipidemia based on network pharmacology and experimental verification. The active components and potential targets of CGE in the treatment of hyperlipidemia were screened through databases such as TCMSP and STRING. The core targets were analyzed through GO functional annotation and KEGG pathway enrichment. The protein-protein interaction network was constructed using the STRING database. Molecular docking technology was used to simulate the binding ability between the active compounds of CGE and the key target proteins. Furthermore,an oleic acid-induced HepG2 cell model was established,and Oil Red O staining,triglyceride (TG) and total cholesterol (TC) assays,as well as Western blot analysis were used to verify the lipid-lowering effect of CGE. After screening and analysis,20 potential targets of CGE were obtained. The core active compounds included naringenin,isosinensetin,and apigenin. The key targets related to the treatment of hyperlipidemia mainly included cysteine-aspartic acid protease 3 ( CASP3),serine/ threonine kinase 1 ( AKT1),and prostaglandin-endoperoxide synthase 2 (PTGS2). GO enrichment analysis indicated that the potential targets of CGE were mainly involved in biological processes such as apoptosis,response to lipopolysaccharide,and protein phosphorylation. KEGG pathway enrichment suggested that CGE was closely related to metabolic pathways and the phosphoinositide 3-kinase/ protein kinase B (PI3K/ AKT) signaling pathway. Molecular docking results showed that the core components exhibited favorable binding activities with the key targets,among which naringenin with CASP3 (-6. 5 kcal/ mol) and apigenin with AKT1 (-6. 15 kcal/ mol) showed the best binding energies. In vitro experiments showed that 0. 2 mmol/ L oleic acid successfully induced lipid accumulation in HepG2 cells, while CGE treatment reduced intracellular lipid droplets in a dose-dependent manner,significantly decreasing the Oil Red O positive area from 39. 89% to 19. 4% -23. 92% ,and markedly lowering TG and TC levels. In addition,CGE inhibited lipid synthesis by suppressing the PI3K/ AKT signaling pathway. This study reveals that CGE alleviates lipid accumulation in HepG2 cells by regulating lipid metabolism-related signaling pathways,which provides a theoretical basis for further investigation of its lipid-lowering mechanism.

Key words:

"> Citri Grandis Exocarpium, hyperlipidemia, network pharmacology, molecular docking, HepG2 cells

中图分类号: 

R285. 5 ','1');return false;" target="_blank"> "> R285. 5